Effect of statin therapy on pulse wave velocity: A meta-analysis of randomized controlled trials

Clin Exp Hypertens. 2018;40(7):601-608. doi: 10.1080/10641963.2017.1411498. Epub 2018 Feb 8.

Abstract

Background and objective: Arterial stiffness (AS) is an independent cardiovascular risk factor. A number of studies have reported a beneficial role of statins on AS albeit with controversial results, in addition to their effects on lipid profile. Therefore, we carried out a meta-analysis of the available randomized controlled trials assessing the effects of statin therapy on AS, in the attempt to reach more definitive conclusions.

Methods: A systematic search of the on-line databases available up to March 2017 was conducted, including intervention studies reporting AS expressed by carotid-femoral pulse wave velocity (PWV), as difference between the effects of treatment with or without statins. For each study, mean difference (MD) and 95% confidence intervals (CI) were pooled using a random effect model.

Results: Eleven studies met the pre-defined inclusion criteria, for a total of 573 participants and 2-144 weeks' intervention time. In the pooled analysis, statin therapy was associated with a -6.8% (95% C.I.: -11.7 to -1.8) reduction in PWV. There was significant heterogeneity among studies (I2 = 96%); none of the study characteristics seems to have influenced the effect of statin use on PWV.

Conclusions: The results of this meta-analysis suggest that statin therapy reduces AS. This effect appears to be at least in part independent of the changes in blood pressure and lipid profile.

Keywords: Arterial stiffness; Cardiovascular disease prevention; HMG-CoA-reductase inhibitors; Meta-analysis; Pulse wave velocity; Statins.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Blood Pressure / drug effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Pulse Wave Analysis
  • Randomized Controlled Trials as Topic
  • Vascular Stiffness / drug effects*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors